Emerging roles of circular RNAs in cancer therapy-induced cardiotoxicity

Cancer therapy-induced cardiotoxicity (CTIC) is an important cause of death in cancer survivors which often results in the withdrawal or discontinuation of drugs. The underlying mechanisms of CTIC remain unclear. Circular RNAs (circRNAs) are a class of non-coding regulatory RNA molecules which have...

Full description

Bibliographic Details
Main Authors: Ziji Cheng, Wanting Qin, Shaoling Li, Shuijin Shao, Baonian Liu
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-03-01
Series:Frontiers in Cardiovascular Medicine
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fcvm.2023.1152436/full
_version_ 1797867192072536064
author Ziji Cheng
Wanting Qin
Shaoling Li
Shuijin Shao
Baonian Liu
author_facet Ziji Cheng
Wanting Qin
Shaoling Li
Shuijin Shao
Baonian Liu
author_sort Ziji Cheng
collection DOAJ
description Cancer therapy-induced cardiotoxicity (CTIC) is an important cause of death in cancer survivors which often results in the withdrawal or discontinuation of drugs. The underlying mechanisms of CTIC remain unclear. Circular RNAs (circRNAs) are a class of non-coding regulatory RNA molecules which have emerged in recent years. They are generated by back splicing and have powerful biological functions, including transcription and splicing, isolating or building macromolecular scaffolds to interfere with microRNA activity and signaling pathways, and acting as templates for translation. Moreover, circRNAs demonstrate high abundance and significant stability. CircRNAs can be used as novel biomarkers because they often function in a cell-type and tissue-specific manner. CircRNAs have attracted increasing attention in cardiovascular disease research, and recent studies exploring the role of circRNAs in CTIC have had promising results. This review will summarize the current understanding of circRNAs’ biogenesis, regulation and function. Their clinical potential as biomarkers, therapeutic agents and drug targets will also be explored.
first_indexed 2024-04-09T23:37:28Z
format Article
id doaj.art-a01d80c63b12459cb1185567623ca6f2
institution Directory Open Access Journal
issn 2297-055X
language English
last_indexed 2024-04-09T23:37:28Z
publishDate 2023-03-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Cardiovascular Medicine
spelling doaj.art-a01d80c63b12459cb1185567623ca6f22023-03-20T05:46:32ZengFrontiers Media S.A.Frontiers in Cardiovascular Medicine2297-055X2023-03-011010.3389/fcvm.2023.11524361152436Emerging roles of circular RNAs in cancer therapy-induced cardiotoxicityZiji Cheng0Wanting Qin1Shaoling Li2Shuijin Shao3Baonian Liu4Department of Anatomy, School of Basic Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, ChinaDepartment of Anatomy, School of Basic Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, ChinaDepartment of Pathology, Shanghai Pulmonary Hospital, School of Medicine, Tongji University, Shanghai, ChinaDepartment of Anatomy, School of Basic Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, ChinaDepartment of Anatomy, School of Basic Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, ChinaCancer therapy-induced cardiotoxicity (CTIC) is an important cause of death in cancer survivors which often results in the withdrawal or discontinuation of drugs. The underlying mechanisms of CTIC remain unclear. Circular RNAs (circRNAs) are a class of non-coding regulatory RNA molecules which have emerged in recent years. They are generated by back splicing and have powerful biological functions, including transcription and splicing, isolating or building macromolecular scaffolds to interfere with microRNA activity and signaling pathways, and acting as templates for translation. Moreover, circRNAs demonstrate high abundance and significant stability. CircRNAs can be used as novel biomarkers because they often function in a cell-type and tissue-specific manner. CircRNAs have attracted increasing attention in cardiovascular disease research, and recent studies exploring the role of circRNAs in CTIC have had promising results. This review will summarize the current understanding of circRNAs’ biogenesis, regulation and function. Their clinical potential as biomarkers, therapeutic agents and drug targets will also be explored.https://www.frontiersin.org/articles/10.3389/fcvm.2023.1152436/fullbiomakercircRNAdoxorubicintherapeutic targetcancer therapy-induced cardiotoxicity
spellingShingle Ziji Cheng
Wanting Qin
Shaoling Li
Shuijin Shao
Baonian Liu
Emerging roles of circular RNAs in cancer therapy-induced cardiotoxicity
Frontiers in Cardiovascular Medicine
biomaker
circRNA
doxorubicin
therapeutic target
cancer therapy-induced cardiotoxicity
title Emerging roles of circular RNAs in cancer therapy-induced cardiotoxicity
title_full Emerging roles of circular RNAs in cancer therapy-induced cardiotoxicity
title_fullStr Emerging roles of circular RNAs in cancer therapy-induced cardiotoxicity
title_full_unstemmed Emerging roles of circular RNAs in cancer therapy-induced cardiotoxicity
title_short Emerging roles of circular RNAs in cancer therapy-induced cardiotoxicity
title_sort emerging roles of circular rnas in cancer therapy induced cardiotoxicity
topic biomaker
circRNA
doxorubicin
therapeutic target
cancer therapy-induced cardiotoxicity
url https://www.frontiersin.org/articles/10.3389/fcvm.2023.1152436/full
work_keys_str_mv AT zijicheng emergingrolesofcircularrnasincancertherapyinducedcardiotoxicity
AT wantingqin emergingrolesofcircularrnasincancertherapyinducedcardiotoxicity
AT shaolingli emergingrolesofcircularrnasincancertherapyinducedcardiotoxicity
AT shuijinshao emergingrolesofcircularrnasincancertherapyinducedcardiotoxicity
AT baonianliu emergingrolesofcircularrnasincancertherapyinducedcardiotoxicity